Department of Internal and Respiratory Medicine, Krankenhaus Nord - Klinik Floridsdorf, Vienna, Austria.
Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Vienna, Austria.
Exp Physiol. 2021 Feb;106(2):532-543. doi: 10.1113/EP088439. Epub 2020 Nov 23.
What is the central question of this study? The study aimed to establish a novel model to study the chronic obstructive pulmonary disease (COPD)-related cardiopulmonary effects of dynamic hyperinflation in healthy subjects. What is the main finding and its importance? A model of expiratory resistance breathing (ERB) was established in which dynamic hyperinflation was induced in healthy subjects, expressed both by lung volumes and intrathoracic pressures. ERB outperformed existing methods and represents an efficacious model to study cardiopulmonary mechanics of dynamic hyperinflation without potentially confounding factors as present in COPD.
Dynamic hyperinflation (DH) determines symptoms and prognosis of chronic obstructive pulmonary disease (COPD). The induction of DH is used to study cardiopulmonary mechanics in healthy subjects without COPD-related confounders like inflammation, hypoxic vasoconstriction and rarefication of pulmonary vasculature. Metronome-paced tachypnoea (MPT) has proven effective in inducing DH in healthy subjects, but does not account for airflow limitation. We aimed to establish a novel model incorporating airflow limitation by combining tachypnoea with an expiratory airway stenosis. We investigated this expiratory resistance breathing (ERB) model in 14 healthy subjects using different stenosis diameters to assess a dose-response relationship. Via cross-over design, we compared ERB to MPT in a random sequence. DH was quantified by inspiratory capacity (IC, litres) and intrinsic positive end-expiratory pressure (PEEPi, cmH O). ERB induced a stepwise decreasing IC (means (95% CI): tidal breathing: 3.66 (3.45-3.88), ERB 3 mm: 3.33 (1.75-4.91), 2 mm: 2.05 (0.76-3.34), 1.5 mm: 0.73 (0.12-1.58) litres) and increasing PEEPi (tidal breathing: 0.70 (0.50-0.80), ERB 3 mm: 11.1 (7.0-15.2), 2 mm: 22.3 (17.1-27.6), 1.5 mm: 33.4 (3.40-63) cmH O). All three MPT patterns increased PEEPi, but to a far lesser extent than ERB. No adverse events during ERB were noted. In conclusion, ERB was proven to be a safe and efficacious model for the induction of DH and might be used for the investigation of cardiopulmonary interaction in healthy subjects.
本研究的核心问题是什么?本研究旨在建立一种新的模型,以研究健康受试者中动态过度充气对慢性阻塞性肺疾病(COPD)相关心肺的影响。主要发现及其重要性是什么?建立了呼气阻力呼吸(ERB)模型,在该模型中,健康受试者中诱导了动态过度充气,这既通过肺容积又通过胸腔内压力来表达。ERB 优于现有方法,是一种有效的模型,可在没有 COPD 相关混杂因素(如炎症、低氧性血管收缩和肺血管稀疏)的情况下研究动态过度充气的心肺力学。
动态过度充气(DH)决定了慢性阻塞性肺疾病(COPD)的症状和预后。DH 的诱导用于研究健康受试者中的心肺力学,而不会受到炎症、低氧性血管收缩和肺血管稀疏等与 COPD 相关的混杂因素的影响。节拍呼吸(MPT)已被证明可有效诱导健康受试者的 DH,但不能考虑到气流受限。我们旨在通过将快速呼吸与呼气气道狭窄相结合,建立一种新的模型来纳入气流受限。我们使用不同的狭窄直径,在 14 名健康受试者中研究了这种呼气阻力呼吸(ERB)模型,以评估剂量反应关系。通过交叉设计,我们以随机顺序比较了 ERB 和 MPT。通过吸气容量(IC,升)和固有正呼气末压(PEEPi,cmH 2 O)来量化 DH。ERB 诱导 IC 呈逐步下降(均值(95%CI):呼吸:3.66(3.45-3.88),ERB 3mm:3.33(1.75-4.91),2mm:2.05(0.76-3.34),1.5mm:0.73(0.12-1.58)升)和 PEEPi 增加(呼吸:0.70(0.50-0.80),ERB 3mm:11.1(7.0-15.2),2mm:22.3(17.1-27.6),1.5mm:33.4(3.40-63)cmH 2 O)。所有三种 MPT 模式都增加了 PEEPi,但远低于 ERB。在 ERB 期间未发现不良事件。总之,ERB 被证明是一种安全有效的 DH 诱导模型,可用于研究健康受试者中心肺相互作用。